📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
17
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
37%
🔄 Reverse Split
40%
• 50-day avg $1.32 approaching $1 threshold
• 11 months cash with weak price
📉 Score Deterioration
40%
• Score rose 20 points recently (worsening)
📜 Warrant Exercise
25%
• Significant warrants: 17% of shares outstanding
💹 Market Data
Market Cap$13.06M
Shares Outstanding9.55M
Float8.73M
Cash$2.13M
Debt$11.65M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest28.5K
Days to Cover4.2
% of Float0.3%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Oct 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2019
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for TAOP
📊 TAOP FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 TAOP Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.